Skip to main content

Bioinformatics Services

Bioinformatics Solutions for Drug Discovery & Disease Analysis

End-to-end bioinformatics services — disease landscape analysis, NGS pipeline development, genomic & transcriptomic data analysis, multi-omics integration, and precision medicine analytics — purpose-built for pharma and biotech.

Get a Free Consultation

What Excelra Does in Bioinformatics

Excelra is a scientific informatics company and leading bioinformatics company with 300+ experts that helps pharmaceutical and biotech organizations turn complex biological data into drug discovery decisions. Founded in 2004, Excelra operates globally serving 50+ pharma and biotech clients across 20+ therapeutic areas. In bioinformatics, Excelra delivers disease landscape analysisNGS pipeline developmentgenomic data analysismulti-omics integration, and precision medicine analytics — combining curated databases, cloud-native pipelines, and domain expertise to accelerate drug discovery from target identification through clinical development. As a bioinformatics company specialising in pharma, Excelra’s work is grounded in the latest scientific literature and aligned with global standards including FAIR data principles and best practices in NGS analysis.

Our Services

End-to-End Bioinformatics Services for Pharma & Biotech

From disease landscape analysis and NGS pipeline development to multi-omics integration and precision medicine analytics.

Disease Landscape Analysis

Scientific and strategic assessment integrating epidemiology, competitive intelligence, biomarker data, and clinical trials. Powered by GoStar & GoBiom.

Disease Landscape Data | Epidemiology
View Service

NGS Pipeline Development

Validated NGS data analysis pipelines — bulk RNA-seqscRNA-seq, WGS, WES via OP 2.0. Built with Nextflow & Snakemake.

Nextflow | Snakemake | scRNA-seq
Learn more

Multi-Omics Integration

Integrate genomics, transcriptomics, proteomics & epigenomics for precision medicine programs. See our omics whitepaper.

Multi-Omics | Transcriptomics
View Service

Biomarker Discovery & Analytics

Identify & validate molecular biomarkers using GoBiom and ML. See our AI biomarker case study and biomarker whitepaper.

Biomarker Analysis | EGoBiom
Learn more

Precision Medicine & Pharmacogenomics

Pharmacogenomics-powered analytics for patient stratification, companion diagnostics, and HEOR & RWE integration.

Pharmacogenomics | Precision Medicine
View Service

DEL Analysis & Genomic Services

DNA-encoded library analysisSAR analysis via GoStar, and hit-to-lead optimization. Plus computational biology services.

DEL Screening | SAR Analysis
Learn more

Most groups pick a corner. We don’t.

Bioinformatics Powerhouse

A Bioinformatics Powerhouse isn’t a slogan — it’s what you get when one team can run an OMICs pipeline on Nextflow, curate a disease landscape from the literature, build a patient-stratification classifier, integrate a knowledge graph, and walk a steering committee through what the data means. All in the same engagement.

🧬

Full-Stack Scientific Expertise

Computational biologists, core domain experts, data scientists, and R&D IT engineers working together across curation, OMICs, AI/ML, consulting, and platform engineering — delivering end-to-end bioinformatics and scientific informatics solutions under one roof.

Curation OMICs AI/ML Consulting
Explore Scientific Expertise →
🤖

AI/ML Built Into the Workflow

Predictive analytics, drug-response classifiers, patient stratification, knowledge graph link prediction, trial benchmarking, and AI-driven cohort analytics — integrated directly into scientific workflows, not added as standalone solutions.

Classifiers Stratification KG Prediction
Explore AI/ML Capabilities →
🧪

Every Modality, Every Scale

From bulk and single-cell RNA-seq to spatial transcriptomics, proteomics, glycoproteomics, metabolomics, WGS/WES, and HLA typing — we build scalable, production-ready OMICS pipelines using Nextflow, Airflow, and Databricks.

Glycoproteomics HLA Typing Metabolomics Airflow
Explore OMICS Capabilities →

Disease Landscape Analysis Services

Disease Landscape Analysis & Insights

Excelra’s disease landscape analysis service delivers a comprehensive scientific and strategic assessment of a therapeutic area — integrating disease landscape data across epidemiology, competitive intelligence, clinical trials, and molecular pathway insights. Built on GoStar, GoBiom, and structured literature mining across 50+ therapeutic areas.

Epidemiology & patient population sizing

Biomarker identification & stratification

Competitive therapeutic landscape mapping

Clinical trial & pipeline analysis

MOA & molecular target insights via GoStar

Structured data for AI/ML integration

Explore Disease Landscape Analysis

Ready to Accelerate Drug Discovery
with Bioinformatics?

Talk to Excelra’s team about disease landscape analysis, NGS pipelines, genomic data analysis, or multi-omics integration. We’ll scope a tailored solution in 48 hours.

How We Work

How Excelra Delivers Bioinformatics Solutions

A structured, scientifically rigorous engagement model designed for pharma and biotech timelines, connected to Excelra’s scientific informatics platform.

Bioinformatics Solutions in Action

How pharma and biotech organizations apply Excelra’s bioinformatics services across biopharmadiagnostics, and animal health.

Accelerating Vaccine R&D with FAIR Data and Optimized Workflows Gap Assessment and Platform Selection

From Bottleneck to Breakthrough: Accelerating GSNAP with Fault-Tolerant Mapping

Accelerating ASO Drug Discovery with Transparent Machine Learning and Enhanced Off-Target Prediction

Accelerating ASO Drug Discovery with Transparent Machine Learning and Enhanced Off-Target Prediction

Data Compendium for MDM2 Inhibitors

Data Compendium for MDM2 Inhibitors

We recently completed a project with Excelra on identifying and prioritizing target opportunities for SLE. The project was delivered successfully and on time. The Excelra team understood and applied our target filtering priorities and responded quickly and precisely to our questions throughout the project. They worked collaboratively and transparently and delivered meaningful data and insights to support our objectives and accelerate our research. We’ve been impressed by Excelra’s professional and qualified team and we’re looking forward to working with them again in the future.

Dr Francois G. Gervais
Executive Director, Discovery Biology

How We Work

Frequently Asked Questions: Bioinformatics Solutions

Common questions about Excelra’s bioinformatics services. More answers in our glossaryblogs, and whitepapers.

What bioinformatics solutions does Excelra offer for drug discovery?

Excelra offers end-to-end bioinformatics solutions including disease landscape analysis, NGS pipeline development, genomic & transcriptomic data analysis, multi-omics integration, DNA-encoded library analysis, biomarker discovery, spatial transcriptomics, and precision medicine analytics — all delivered by 300+ scientific informatics experts with 15+ years of pharma experience.

What is disease landscape analysis and how does it support drug development?

Disease landscape analysis is a comprehensive scientific and strategic assessment of a therapeutic area integrating epidemiology, competitive intelligence, biomarker data, clinical trial analysis, and molecular insights. Excelra’s disease landscape analysis service is ranked #1 on Google and built on GoStar, GoBiom, and structured literature mining across 50+ therapeutic areas.

What NGS pipeline workflows does Excelra support?

Excelra supports bulk RNA-seq, single-cell transcriptomics, WGS, WES, ChIP-seq, ATAC-seq, immunomics, and spatial transcriptomics pipelines — built with Nextflow and Snakemake on AWS, GCP, and Azure. See our NGS pipeline case study.

What is transcriptomics and how does Excelra use it?

Transcriptomics is the study of the complete set of RNA transcripts produced by a genome. In drug discovery it reveals differentially expressed genes, disease mechanisms, and drug response signatures. Excelra delivers bulk, single-cell, and spatial transcriptomics via the Online Pipeline Platform (OP 2.0).

What is multi-omics and how does it support precision medicine?

Multi-omics integrates genomics, transcriptomics, proteomics, metabolomics, and epigenomics to build a comprehensive molecular disease model. In precision medicine, it enables patient stratification, identifies companion diagnostic biomarkers, and predicts individual drug response.

What is pharmacogenomics and does Excelra offer these services?

Pharmacogenomics studies how genetic variations influence an individual’s response to drugs. Excelra integrates pharmacogenomic analysis into precision medicine services, linking genetic variants to drug response for companion diagnostic programs.

What is the difference between bioinformatics and computational biology?

Bioinformatics focuses on algorithms and pipelines for processing large-scale biological data. Computational biology applies mathematical modeling to simulate biological systems. Excelra provides both — bioinformatics for data processing and pipeline development, and computational biology for PBPK modeling, QSP/QST, and systems pharmacology.

Does Excelra provide bioinformatics services for biotech startups?

Yes. Excelra works with biotech startups through flexible engagement models — cloud infrastructure, pipeline development, and genomics analysis — without the overhead of an in-house team. See: 4 Bioinformatics Expertise Sources for Biotech Startups.

Talk to Excelra’s bioinformatics team today.

300+ scientific informatics experts · 50+ pharma & biotech clients · 15+ years experience

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Country **
By registering, you agree to our Privacy Policy. You can review your consent preferences anytime. You also have the right to withdraw consent, correct or access your data.
Excelra mails